New drug tested for Tough-to-Treat lymphoma in japan
NCT ID NCT04533581
Summary
This study is testing an experimental drug called ME-401 in Japanese patients whose slow-growing B-cell lymphoma has come back or stopped responding to at least two prior treatments. The main goal is to see how well the drug shrinks the cancer and how safe it is for patients. Researchers will measure how many patients respond to treatment and how long the benefits last.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INDOLENT B-CELL NON-HODGKIN'S LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aichi Cancer Center Hospital
Nagoya, Aichi-ken, Japan
-
Akita University Hospital
Akita, Japan
-
Anjo Kosei Hospital
Anjo, Aichi-ken, Japan
-
Aomori Prefectural Central Hospital
Aomori, Japan
-
Chiba Cancer Center
Chiba, Japan
-
Chugoku Central Hospital
Fukuyama, Hiroshima, Japan
-
Gunma University Hospital
Maebashi, Gunma, Japan
-
Hokkaido University Hospital
Sapporo, Hokkaido, Japan
-
Ishikawa Prefectural Central Hospital
Kanazawa, Ishikawa-ken, Japan
-
Japanese Red Cross Kyoto Daini Hospital
Kyoto, Japan
-
Japanese Red Cross Nagoya Daini Hospital
Nagoya, Aichi-ken, Japan
-
Jichi Medical University Hospital
Shimotsuke, Tochigi, Japan
-
Kagoshima University Hospital
Kagoshima, Japan
-
Kameda Medical Center
Kamogawa, Chiba, Japan
-
Kindai University Hospital
Sayama, Osaka, Japan
-
Kurashiki Central Hospital
Kurashiki, Okayama-ken, Japan
-
Kyushu University Hospital
Fukuoka, Japan
-
Mie University Hospital
Tsu, Mie-ken, Japan
-
National Cancer Center Hospital
Chuo-ku, Tokyo, Japan
-
National Hospital Organization Kumamoto Medical Center
Kumamoto, Japan
-
National Hospital Organization Kyushu Medical Center
Fukuoka, Japan
-
National Hospital Organization Nagoya Medical Center
Nagoya, Aichi-ken, Japan
-
National Hospital Organization Shikoku Cancer Center
Matsuyama, Ehime, Japan
-
Okayama University Hospital
Okayama, Japan
-
Osaka University Hospital
Suita, Osaka, Japan
-
Saitama Medical University International Medical Center
Hidaka, Saitama, Japan
-
The Cancer Institute Hospital Of JFCR
Koto-ku, Tokyo, Japan
-
Tohoku University Hospital
Sendai, Miyagi, Japan
-
Tokyo Metropolitan Komagome Hospital
Bunkyo-ku, Tokyo, Japan
-
Tottori University Hospital
Yonago, Tottori, Japan
Conditions
Explore the condition pages connected to this study.